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0% CABG, 0% reintervention, 2% rehospitalization for
CHF, 1.4% rehospitalization for ACS.
Conclusion: CTO requires endless patience from the
cardiologist. There is no need to abuse the resources of
the cath lab if we follow the protocol of TO BELIEVERS.
Excellent results can be obtained if CTO intervention
done by using these basic equipments.
http://dx.doi:10.1016/j.jsha.2013.03.170
Statin and ezetimibe in silent ambulatory myocar-
dial ischemia (sesami trial)
Waleed Y. Kadro, Maya Turkmani, Hussam
Rahim, Owais Altisheh, Ali Debs
Background: Cholesterol lowering is associated with
a reduction in cardiovascular morbidity and mortality.
Statins are the main drugs for cholesterol lowering. Eze-
timibe when added to statins gives further reduction in
cholesterol but its long-term effect on cardiovascular
morbidity and mortality and ischemic events is not
known. This study sought to determine whether further
cholesterol lowering with ezitimibe will also results in a
reduction of myocardial ischemia during daily life.
Methods: We enrolled 50 patients with proven stable
coronary artery disease (CAD) and at least one episode of
ST-segment depression on ambulatory ECG monitoring.
All of them were receiving optimal therapy for CAD
including statin therapy for cholesterol reduction. 25
patients were randomized to continue their statin ther-
apy (Statin only group) and 25 to recieve statin plus ezi-
timibe 10 mg/day (ezitimibe group). Serum cholesterol
and LDL cholesterol levels and ambulatory monitoring
were repeated after 4–6 months of therapy. The two
groups were comparable with respect to baseline charac-
teristics, number of episodes of ST-segment depression,
and baseline serum cholesterol levels. Holters were read
by a blinded cardiologist.
Results: The ezitimibe group had lower mean total
and LDL cholesterol levels at study end and experienced
a significant reduction in the number of episodes of ST-
segment depression compared with the statin only
group. ST-segment depression was completely resolved
in 13 of 25 patients (52%) in the ezitimibe group versus
3 of 25 (12%) in the statin only group. The ezitimibe group
exhibited a highly significant reduction in ambulatory
ischemia (P < .001). By logistic regression, treatment with
ezitimibe was an independent predictor of ischemia
resolution.
Conclusions: Further cholesterol lowering with ezi-
timibe can result in reduction or resolution of myocardial
ischemia recorded as episodes of ST-segment depression
in ambulatory monitoring of the ECG.
http://dx.doi:10.1016/j.jsha.2013.03.171
Troponin level before coronary artery bypass graft
surgery is associated with increased mortality rate
Walid Abukhudair, Massimo Porqueddo,
Nazir Ahmed, Ahmed Hafed, Abdullah Ashmeg,
Thamer Bin Yousef
Objective: Cardiac troponin level indicate extend of
miocardial injury.
Coronary artery bypass graft surgery early post myo-
cardial infartion is associated with high mortality, trying
to find a quantitative piameter to determine the high risk
patients.
Method: Prospective data collection of troponin level
and outcome of coronary artery bypass graft surgery was
collected over 3 years (30 days mortality).
Result: A total of 550 patients who had CABG over
3 years was collected, the patients were divided into 3
groups. Group 1 patient with troponin less than 3. Group
2 patient with troponin between 3 and 5. Group 3 patient
with troponin above 5. The 30 days mortality was propor-
tionally correlated to the troponin level. Group 1 had a
mean mortality of less than 2%, group 2 had a mean mor-
tality of 3.5%, and group 3 had a mean mortality rate of
10%.
Conclusion: Preoperative 30 days mortality post
CABG is proportionally related to the extend of myocar-
dial damage which is reflected by trop in level. When
possible it is better to wait and delay surgery until tropo-
nin level below 3.
http://dx.doi:10.1016/j.jsha.2013.03.172
Proper method for preoperative chest preparation
of patients listed for cardiac surgery
Walid Abdulkarim Abukhudair
Context: Postoperative pulmonary complication
(PCCs) after cardiac surgery are a major source of mor-
bidity and mortality, and increase length of hospital stay
and resource utilization. The preoperative including pre-
hospitlization period before CARDIAC surgery maybe
used to improve a patients pulmonary condition. The
efficacy of preoperative non-invasive CPAP and BIPAP
machine use, chest physiotherapy (CPT) and postural
drainage, frequent nebulization plus inspiratory muscle
training (IMT) in reducing the incidence of PPCs in
high-risk patients undergoing CARDIAC surgery has
not yet been determined.
Objective: To evaluate the prophylactic efficacy of
our new preoperative chest preparation strategy (strategy
A) on the incidence of PPCs in high risk patients sched-
uled for elective CARDIAC surgery compared with clas-
sic routinely used one (Strategy B).
Design, setting, and patients: A single blind,
randomized clinical trial conducted at the Cardiac
Center of Kind Fahad Armed forces Hospital, Jeddah,
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